Universal Health Services Inc (UHS) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Universal Health Services Inc   (NYSE: UHS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Universal Health Services Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Universal Health Services Inc 's ROA in the third quarter of 2026?
Universal Health Services Inc achieved a return on average assets (ROA) of 7.26 % in its third quarter of 2026, this is above UHS's average return on assets of 7.09%.
Universal Health Services Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $20 billion

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 95 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 607, from total ROA ranking in the second quarter of 2026 at 706.

What is ROA?



Return On Assets (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 9.67 % 47.27 % 8.39 % 56.62 % 46.2 %
Y / Y Net Income Change -18.58 % 0.55 % 11.52 % 32.87 % 42.57 %
Net Income (TTM) in million 1,480 1,550 1,548 1,511 1,400
Return On Assets (TTM) 7.26 % 7.79 % 8.52 % 8.46 % 8.82 %
UHS's Total Ranking # 607 # 706 # 660 # 716 # 753
Total Assets (TTM) in million 22,344 21,501 15,681 22,009 20,373
Seq. Total Assets Change 3.92 % 37.12 % -28.75 % 8.03 % 39.55 %
Seq. Net Income Change -15.33 % 1.65 % -19.91 % 18.13 % 4.55 %



Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 96
Overall # 607

Return On Assets Statistics
High Average Low
10.06 %
7.09 %
4.9 %
(Mar 31 2026)   (Sep 30 2023)





Financial Statements
Universal Health Services Inc 's Assets $ 22,344 million UHS's Balance sheet
Universal Health Services Inc 's Income $ 309 million Quarterly UHS's Income Statement
UHS's Income by Division See UHS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 10.49 % 3.82 % 3.79 % 2.46 % -3.16 %
Total Assets in million 15,528 14,053 13,536 13,042 12,728
Y / Y Net Income Change 29.93 % 61.7 % 9.49 % -33.48 % 3.66 %
Net Income in million 1,511 1,163 719 657 988
Annual Return On Assets 9.73 % 8.28 % 5.31 % 5.04 % 7.76 %




Comment on UHS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 9.73 % compared to prior year, due to annual net income growth of 29.93 % to $1,511.18 million, while value of Universal Health Services Inc 's overall assets grew just by 10.49 % to $15,527.59 million, compared to $15,527.59 a year before.


More Return On Assets Ratios
UHS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
UHS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for UHS's Competitors
Subscribers only: Roa for Universal Health Services Inc 's Suppliers
Subscribers only: Return On Assets for UHS's Customers

You may also want to know
UHS's Roi UHS's Inventory Turnover Ratio UHS's Growth Rates UHS's Dividend Comparisons
UHS's Profitability Ratios UHS's Asset Turnover Ratio UHS's Dividend Growth
UHS's Roe UHS's Valuation Ratios UHS's Financial Strength Ratios UHS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Beone Medicines Ltd   10.23 %
Amgen Inc   10.02 %
Bio rad Laboratories Inc   9.88 %


Date modified: 2026-11-07T13:14:08+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.